Home Clinical Trial Investigator Nebraska-based Meridian Clinical Research Expands Site Network with Acquisition of Regional Clinical...

Nebraska-based Meridian Clinical Research Expands Site Network with Acquisition of Regional Clinical Research

105
0
Nebraska-based Meridian Clinical Research Expands Site Network with Acquisition of Regional Clinical Research

Omaha, NE-based Meridian Clinical Research, LLC acquired the assets and operations of Regional Clinical Research, Inc. in yet another clinical investigator site acquisition.  TrialSite News covers ongoing drive for consolidation and rationalization in what is largely a fragmented clinical research site marketplace. Biopharma and CRO sponsor buyers seek more integrated offerings.

By absorbing Regional Clinical Research, Meridian picks up four research sites in the southern tier of New York. Both commercial research sites are members of Platinum Research Network. 

Founded in 1993 by Bruce Bowling, MD, and Victor Elinoff, MD, they focused in infectious disease, neurology and women’s health. Nicole Osborn, founder and CEO of Meridian, noted in their press release that “This is a perfect addition” as she emphasized “We’ve known Regional’s leaders and collaborated on the best practice for years. Their teams shares our mentality and our sense of purpose for patient-centric research.”

Median Clinical Research Background

Aligned with several of the top dozen tier-one biopharmaceutical companies and most of the largest contract research organizations (CROs), Meridian partners with biopharma companies to research drugs, devices and diagnostics that could improve human health and well-being. Founded in 1999, Meridian maintains a dedicated research center in Omaha, NE. There, they specialize in conducting Phase I-VI studies at investigative sites across North America. Meridian supports research in a wide range of therapeutic areas and specializes in high-volume vaccine trials.

Meridian employs approximately 75 to 100 with its main headquarters in Nebraska. Revenues are estimated to be $15 million to $20 million.

They maintain a network of research sites in Georgia, Louisiana, Maryland, Nebraska, South Dakota, Virginia and some presence in Mexico. Meridian reports that it has enrolled over 24,000 patients and conducted 1,500 studies.

Meridian is part of the “Platinum Research Network.” A network of research sites, it was formed in 2014 as a solution for research companies. The network consists of highly-experienced clinical research companies that share a common goal of delivering high quality data and predictable enrollment for clinical trials. They include locations in over a dozen states. Participants in the Platinum Research Network includes:

  • Medpharmics
  • Meridian Clinical Research
  • Regional Clinical Research
  • Sterling Research
  • Sundance Clinical Research
  • Tekton Research
  • Ventavia Research Group

Regional Clinical Research, Inc.

Now part of Meridian Clinical Research, Regional Clinical Research was formed in 1992. It began as a part-time clinical research coordination outfit and grew into a small business, which employs 25 and maintains offices through the Southern Tier of NY. By 2002, they joined forces with United Health Services Hospitals to conduct their out-patient research.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.